BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 19334793)

  • 21. Bladder-Rectum Spacer Balloon versus Vaginal Gauze Packing in High Dose Rate Brachytherapy in Cervical Cancer: A Randomised Study. Part II.
    Rai B; Patel FD; Chakraborty S; Kapoor R; Sharma SC; Kumaravelu S; Raghukumar P; Aprem AS
    Clin Oncol (R Coll Radiol); 2015 Dec; 27(12):713-9. PubMed ID: 26144319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dosimetric analysis at ICRU reference points in HDR-brachytherapy of cervical carcinoma.
    Eich HT; Haverkamp U; Micke O; Prott FJ; Müller RP
    Rontgenpraxis; 2000; 53(2):62-6. PubMed ID: 10994367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo diode dosimetry vs. computerized tomography and digitally reconstructed radiographs for critical organ dose calculation in high-dose-rate brachytherapy of cervical cancer.
    Hassouna AH; Bahadur YA; Constantinescu C; El Sayed ME; Naseem H; Naga AF
    Brachytherapy; 2011; 10(6):498-502. PubMed ID: 21640661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CT-based 3D dose-volume parameter of the rectum and late rectal complication in patients with cervical cancer treated with high-dose-rate intracavitary brachytherapy.
    Kato S; Tran DN; Ohno T; Nakano T; Kiyohara H; Ohkubo Y; Kamada T
    J Radiat Res; 2010; 51(2):215-21. PubMed ID: 20339256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of radiography- and computed tomography-based treatment planning in cervix cancer in brachytherapy with specific attention to some quality assurance aspects.
    Fellner C; Pötter R; Knocke TH; Wambersie A
    Radiother Oncol; 2001 Jan; 58(1):53-62. PubMed ID: 11165682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of dosimetric and clinical parameters on clinical side effects in cervix cancer patients treated with 3D pulse-dose-rate intracavitary brachytherapy.
    Levitchi M; Charra-Brunaud C; Quetin P; Haie-Meder C; Kerr C; Castelain B; Delannes M; Thomas L; Desandes E; Peiffert D
    Radiother Oncol; 2012 Jun; 103(3):314-21. PubMed ID: 22633813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of conventional and CT-based planning for intracavitary brachytherapy for cervical cancer: target volume coverage and organs at risk doses.
    Onal C; Arslan G; Topkan E; Pehlivan B; Yavuz M; Oymak E; Yavuz A
    J Exp Clin Cancer Res; 2009 Jul; 28(1):95. PubMed ID: 19570212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of 2D vs. 3D dosimetry for Rotte 'Y' applicator high dose rate brachytherapy for medically inoperable endometrial cancer.
    Beriwal S; Kim H; Heron DE; Selvaraj R
    Technol Cancer Res Treat; 2006 Oct; 5(5):521-7. PubMed ID: 16981795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survey of the use of the ICRU 38 in recording and reporting cervical cancer brachytherapy.
    Pötter R; Van Limbergen E; Gerstner N; Wambersie A
    Radiother Oncol; 2001 Jan; 58(1):11-8. PubMed ID: 11165676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 3D CT-based volumetric dose assessment of 2D plans using GEC-ESTRO guidelines for cervical cancer brachytherapy.
    Gao M; Albuquerque K; Chi A; Rusu I
    Brachytherapy; 2010; 9(1):55-60. PubMed ID: 19853536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Three-dimension anatomy-based planning optimization for high dose rate vaginal vault brachytherapy.
    Bahadur YA; Hassouna AH; Constantinescu CT; Naga AF; Ghasal NM; Elsayed ME
    Saudi Med J; 2012 Jun; 33(6):640-7. PubMed ID: 22729119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Three-dimensional image-based planning for cervix brachytherapy with bilateral hip prostheses: a solution using MVCT with helical tomotherapy.
    Korol RM; Surry K; Davidson MT; Yartsev S; Rodrigues G; D'Souza DP
    Brachytherapy; 2010; 9(3):278-81. PubMed ID: 20189887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Computed axial tomography tandem and ovoids (CATTO) dosimetry: three-dimensional assessment of bladder and rectal doses.
    Gebara WJ; Weeks KJ; Hahn CA; Montana GS; Anscher MS
    Radiat Oncol Investig; 1998; 6(6):268-75. PubMed ID: 9885943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proposed guidelines for image-based intracavitary brachytherapy for cervical carcinoma: report from Image-Guided Brachytherapy Working Group.
    Nag S; Cardenes H; Chang S; Das IJ; Erickson B; Ibbott GS; Lowenstein J; Roll J; Thomadsen B; Varia M;
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1160-72. PubMed ID: 15519788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Computed tomography-based high-dose-rate intracavitary brachytherapy for uterine cervical cancer: preliminary demonstration of correlation between dose-volume parameters and rectal mucosal changes observed by flexible sigmoidoscopy.
    Koom WS; Sohn DK; Kim JY; Kim JW; Shin KH; Yoon SM; Kim DY; Yoon M; Shin D; Park SY; Cho KH
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1446-54. PubMed ID: 17482766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can point doses predict volumetric dose to rectum and bladder: a CT-based planning study in high dose rate intracavitary brachytherapy of cervical carcinoma?
    Patil VM; Patel FD; Chakraborty S; Oinam AS; Sharma SC
    Br J Radiol; 2011 May; 84(1001):441-8. PubMed ID: 21511749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interfraction physical dose variations in high-dose-rate brachytherapy for carcinoma cervix based on computed tomography image dataset to find the compatibility of the first fraction plan to treat successive fractions.
    Yadav S; Singh OP; Choudhary S; Saroj DK; Maurya AK; Yogi V
    J Cancer Res Ther; 2019; 15(6):1304-1308. PubMed ID: 31898664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Image-guided cervix high-dose-rate brachytherapy treatment planning: does custom computed tomography planning for each insertion provide better conformal avoidance of organs at risk?
    Davidson MT; Yuen J; D'Souza DP; Batchelar DL
    Brachytherapy; 2008; 7(1):37-42. PubMed ID: 18299111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The dosimetric impact of heterogeneity corrections in high-dose-rate ¹⁹²Ir brachytherapy for cervical cancer: Investigation of both conventional Point-A and volume-optimized plans.
    Hyer DE; Sheybani A; Jacobson GM; Kim Y
    Brachytherapy; 2012; 11(6):515-20. PubMed ID: 22386723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inter fraction variations in rectum and bladder volumes and dose distributions during high dose rate brachytherapy treatment of the uterine cervix investigated by repetitive CT-examinations.
    Hellebust TP; Dale E; Skjønsberg A; Olsen DR
    Radiother Oncol; 2001 Sep; 60(3):273-80. PubMed ID: 11514007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.